Back to Search
Start Over
Anticancer Effect of Rh2, a Histone Deacetylase Inhibitor, in HepG2 Cells and HepG2 Cell-Derived Xenograft Tumors Occurs via the Inhibition of HDACs and Activation of the MAPK Signaling Pathway.
- Source :
-
Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2021 Aug 01; Vol. 22 (8), pp. 2529-2539. Date of Electronic Publication: 2021 Aug 01. - Publication Year :
- 2021
-
Abstract
- Purpose: To investigate the effect of 20(S)-ginsenoside Rh2 (Rh2) on anti HepG2 liver cancer cells and HepG2 cell-derived xenograft tumors, and explore the underlying mechanisms.<br />Materials and Methods: The activity of total HDACs and HAT were assessed with a HDACs colorimetric kit. Expression of HDAC1, HDAC2, HDAC6, p-ERK, ERK, p-P38, P38, p-JNK and JNK proteins was tested by Western blotting.H3K9 and H3K14 proteins were also checked by immunofluorescence, changes in cell cycle distribution with flow cytometry, cell apoptosis with annexin V-FTIC/PI double staining. Activity of Renilla luciferase (HIF) was detected using the Luciferase Reporter Assay system reagent. Gene expression for CyclinD1, Bcl-2, Bax, HIF, IL-1, IL-6, IL-10 and TNF-α was tested by q-PCR. Expression levels of CD31 and Ki-67 was tested by immunohistochemical staining.<br />Results: Total HDAC activity was decreased and total histone acetyltransferase (HAT)activity was increased in a time-dependent manner. Expression of HDAC1 and p-JNK proteins was significantly increased, expression levels of p-ERK was decreased. H3K9 and H3K14 fluorescence protein were increased. Flow cytometric analysis of the cell cycle revealed that the percentage of cells in the G0/G1 phase in the treatment group(64.35±1.36%) was significantly increased compared with the untreated group(61.61±1.23%).The apoptotic rate of the HepG2 group was 10.03±1.92%, which increased to 17.87±1.67% in the treatment group. Expression levels of the transcription factor HIF were also increased in HepG2 cells following induction by Rh2. Expression of CyclinD1 and Bcl-2 at the genetic level was significantly decreased, while expression levels of Bax, HIF, IL-1, IL-6, IL-10 and TNF-α was increased. In vivo, the expression levels of both CD31 and Ki-67 proteins were significantly down-regulated in the treatment group compared with the control group.<br />Conclusions: The effects of Rh2 were suggested to occur through the inhibition of total HDAC activity, which subsequently induced MAPK signaling and down-regulated the expression of HIF.<br />.
- Subjects :
- Animals
Apoptosis
Carcinoma, Hepatocellular metabolism
Carcinoma, Hepatocellular pathology
Cell Movement
Cell Proliferation
Humans
Liver Neoplasms metabolism
Liver Neoplasms pathology
Mice
Mice, Inbred BALB C
Mice, Nude
Signal Transduction
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
Carcinoma, Hepatocellular drug therapy
Gene Expression Regulation, Neoplastic drug effects
Ginsenosides pharmacology
Histone Deacetylase Inhibitors pharmacology
Histone Deacetylases chemistry
Liver Neoplasms drug therapy
MAP Kinase Signaling System drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 2476-762X
- Volume :
- 22
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Asian Pacific journal of cancer prevention : APJCP
- Publication Type :
- Academic Journal
- Accession number :
- 34452568
- Full Text :
- https://doi.org/10.31557/APJCP.2021.22.8.2529